Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
NCT01037309
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
PRO044 SC
DRUG:
PRO044 IV
Sponsor
BioMarin Pharmaceutical